267 trials changed in the last 30 days: 1 stopped, 100 with notable changes, 166 with minor changes only.
Trial terminated
Also in this update: Final enrollment: 8 participants — 7% of the 120 planned; Primary completion date changed from estimate of Nov 30, 2026 to Sep 11, 2026
Verdiva Bio Dev LimitedPhase 2 NCT07553299 Registry history of NCT07553299 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 30, 2027 to Dec 30, 2027
Also in this update: Trial sites expanded: 12 → 27 locations; Study completion pushed from May 1, 2027 to Sep 30, 2029; and 4 more changes in the last 30 days
Morphic Medical Inc.Not applicable NCT04101669 Registry history of NCT04101669 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 4, 2027 to Apr 6, 2028
AstraZenecaPhase 3 NCT07775404 Registry history of NCT07775404 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Feb 28, 2026 to Oct 31, 2026
Also in this update: Enrollment closed, study ongoing; Study completion pushed from May 31, 2026 to Nov 30, 2026
Seattle Children's HospitalPhase 2 NCT06299891 Registry history of NCT06299891 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 2026 to Oct 2027
Also in this update: Study completion pushed from Jul 2026 to Dec 2027
Dr. Md. Alimur RezaNot specified NCT07099742 Registry history of NCT07099742 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 2025 to Nov 2031
Also in this update: Primary endpoint(s) modified; Enrollment increased: 5 → 60 participants
University of Colorado, DenverPhase 1 NCT06414096 Registry history of NCT06414096 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2024 to Dec 2030
Also in this update: Enrollment reduced: 10000 → 8320 participants; Study completion pushed from Dec 2029 to Jun 2034
Medical University of BialystokNot specified NCT03197363 Registry history of NCT03197363 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Sep 2027
Also in this update: Recruitment opened; Study completion pushed from Jun 2027 to Sep 2027
Dicle UniversityNot applicable NCT07770711 Registry history of NCT07770711 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027
Oklahoma State UniversityNot applicable NCT06970457 Registry history of NCT06970457 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Jul 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Apr 2027 to Jul 2027
Tulane UniversityNot applicable NCT06116149 Registry history of NCT06116149 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Oct 2027
Also in this update: Study completion pushed from Oct 2026 to Oct 2027
Brigham and Women's HospitalNot applicable NCT05938543 Registry history of NCT05938543 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 16, 2026 to Jun 16, 2028
Duke UniversityNot specified NCT06604650 Registry history of NCT06604650 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
Also in this update: Study completion pushed from Mar 2027 to Sep 2027
Johns Hopkins UniversityNot applicable NCT06364644 Registry history of NCT06364644 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 30, 2026 to Jul 30, 2027
Also in this update: Recruitment opened; Study completion pushed from Jul 30, 2026 to Sep 30, 2027
Arkansas Children's Hospital Research InstituteNot applicable NCT06666257 Registry history of NCT06666257 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2026 to Dec 2027
Also in this update: Primary endpoint(s) modified; Study completion pushed from Dec 2026 to Mar 2028
Columbia UniversityNot applicable NCT06853288 Registry history of NCT06853288 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 30, 2026 to Oct 30, 2027
Also in this update: Primary endpoint(s) modified; Study completion pushed from Dec 31, 2026 to Dec 31, 2027; and 1 more change in the last 30 days
Wake Forest University Health SciencesPhase 4 NCT06861439 Registry history of NCT06861439 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 1, 2026 to Apr 10, 2027
Also in this update: Enrollment closed, study ongoing; Trial sites expanded: 1 → 20 locations
Rijnstate HospitalPhase 4 NCT06184633 Registry history of NCT06184633 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 1, 2026 to May 25, 2028
Also in this update: Study completion pushed from Aug 1, 2026 to Jun 25, 2028
The University of Texas Health Science Center, HoustonPhase 2 NCT06173778 Registry history of NCT06173778 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 30, 2026 to Apr 30, 2027
Also in this update: Study completion pushed from Aug 31, 2026 to Aug 31, 2027
Michigan State UniversityNot applicable NCT04213014 Registry history of NCT04213014 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Dec 31, 2028
Also in this update: Study completion pushed from Dec 31, 2027 to Jun 1, 2029
Brigham and Women's HospitalNot applicable NCT05560971 Registry history of NCT05560971 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 27, 2025 to Mar 17, 2026
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.Phase 3 NCT06704581 Registry history of NCT06704581 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Regeneron PharmaceuticalsPhase 2 NCT07477704 Registry history of NCT07477704 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 2028 to Jan 12, 2026
Soleno Therapeutics, Inc.Phase 3 NCT05701774 Registry history of NCT05701774 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Apr 2027 to Oct 2027
Alveus Therapeutics, Inc.Phase 1 NCT07399678 Registry history of NCT07399678 on ClinicalTrials.gov (opens the registry)
Trial completed
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsPhase 2 NCT07169942 Registry history of NCT07169942 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Feb 12, 2026 to Apr 9, 2026
BrightGene Bio-Medical Technology Co., Ltd.Phase 1 NCT07382908 Registry history of NCT07382908 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 2, 2026 to Jun 5, 2026
BrightGene Bio-Medical Technology Co., Ltd.Phase 1 NCT07294235 Registry history of NCT07294235 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 12, 2026 to May 13, 2026
BrightGene Bio-Medical Technology Co., Ltd.Phase 1 NCT07166081 Registry history of NCT07166081 on ClinicalTrials.gov (opens the registry)
Trial completed
BrightGene Bio-Medical Technology Co., Ltd.Phase 2 NCT06911203 Registry history of NCT06911203 on ClinicalTrials.gov (opens the registry)
Trial completed
BrightGene Bio-Medical Technology Co., Ltd.Phase 1 NCT07224399 Registry history of NCT07224399 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of May 21, 2027 to Sep 16, 2026
AstraZenecaPhase 1 NCT07220954 Registry history of NCT07220954 on ClinicalTrials.gov (opens the registry)
Trial completed
BrightGene Bio-Medical Technology Co., Ltd.Phase 1 NCT07239973 Registry history of NCT07239973 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 100 participants (planned 50)
AstraZenecaPhase 1 NCT07013643 Registry history of NCT07013643 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Sep 30, 2026 to Aug 30, 2026
Vincentage Pharma Co., LtdPhase 1 NCT07349381 Registry history of NCT07349381 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Eli Lilly and CompanyPhase 2 NCT07215559 Registry history of NCT07215559 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion moved earlier from Nov 1, 2027 to May 7, 2027; Final enrollment: 111 participants (planned 150)
Rhythm Pharmaceuticals, Inc.Phase 1/2 NCT06239116 Registry history of NCT06239116 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
KaileraPhase 3 NCT07284979 Registry history of NCT07284979 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites expanded: 104 → 110 locations
KaileraPhase 3 NCT07284875 Registry history of NCT07284875 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites expanded: 167 → 173 locations
KaileraPhase 3 NCT07284901 Registry history of NCT07284901 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jul 2, 2026 to Aug 3, 2026
Corbus Pharmaceuticals Inc.Phase 1 NCT07310901 Registry history of NCT07310901 on ClinicalTrials.gov (opens the registry)
Trial completed
Carmot Therapeutics, Inc.Phase 2 NCT06628362 Registry history of NCT06628362 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Eli Lilly and CompanyPhase 3 NCT07153471 Registry history of NCT07153471 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion moved earlier from Sep 29, 2027 to Aug 30, 2027
AmgenPhase 3 NCT07226765 Registry history of NCT07226765 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Jul 2026 to Mar 7, 2026
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 NCT06738979 Registry history of NCT06738979 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
AmgenPhase 3 NCT07225686 Registry history of NCT07225686 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Sep 30, 2026 to Dec 31, 2026; Final enrollment: 99 participants (planned 124)
VA Office of Research and DevelopmentNot applicable NCT05225233 Registry history of NCT05225233 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Antag TherapeuticsPhase 2 NCT07724340 Registry history of NCT07724340 on ClinicalTrials.gov (opens the registry)
Trial completed
Eli Lilly and CompanyPhase 2 NCT06603571 Registry history of NCT06603571 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion moved earlier from Dec 22, 2027 to Nov 17, 2027; Primary completion moved earlier from Sep 29, 2027 to Aug 25, 2027
AmgenPhase 2 NCT07441252 Registry history of NCT07441252 on ClinicalTrials.gov (opens the registry)
Trial completed
AstraZenecaPhase 2 NCT06851858 Registry history of NCT06851858 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Innovent Biologics (Suzhou) Co. Ltd.Phase 2 NCT06862908 Registry history of NCT06862908 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion moved earlier from Nov 2027 to Aug 2027
Eli Lilly and CompanyPhase 4 NCT06864026 Registry history of NCT06864026 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jul 15, 2025 to Jul 15, 2024
MindRank AI LtdPhase 1/2 NCT06778850 Registry history of NCT06778850 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Oregon Research InstitutePhase 2 NCT07226336 Registry history of NCT07226336 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 20 participants (planned 15)
Columbia UniversityPhase 1 NCT06592261 Registry history of NCT06592261 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from May 4, 2027 to Jun 18, 2027
Novo Nordisk A/SPhase 1 NCT07525791 Registry history of NCT07525791 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1 NCT07559136 Registry history of NCT07559136 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Boehringer IngelheimPhase 1 NCT07693231 Registry history of NCT07693231 on ClinicalTrials.gov (opens the registry)
Trial completed
AmgenPhase 1 NCT07229157 Registry history of NCT07229157 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 200 participants (planned 225)
Eli Lilly and CompanyPhase 1 NCT06148272 Registry history of NCT06148272 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of MelbournePhase 4 NCT06191848 Registry history of NCT06191848 on ClinicalTrials.gov (opens the registry)
Trial completed
Samara State Medical UniversityNot specified NCT05920785 Registry history of NCT05920785 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 22 participants (planned 60)
Duke UniversityNot applicable NCT05608668 Registry history of NCT05608668 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion pushed from Sep 2026 to Jan 2027; Final enrollment: 28 participants (planned 25)
University of California, DavisNot applicable NCT06032104 Registry history of NCT06032104 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Nakhia Impex LLCNot applicable NCT07583108 Registry history of NCT07583108 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of Illinois at ChicagoNot applicable NCT06477120 Registry history of NCT06477120 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 317 participants (planned 242)
University of PennsylvaniaNot applicable NCT05783765 Registry history of NCT05783765 on ClinicalTrials.gov (opens the registry)
Trial status changed: Unknown → Completed
Also in this update: Primary completion date changed from estimate of May 30, 2026 to Sep 30, 2026
All India Institute of Medical Sciences, BhubaneswarNot applicable NCT06413264 Registry history of NCT06413264 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterNot applicable NCT05053113 Registry history of NCT05053113 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Apr 2026 to Sep 28, 2026; Final enrollment: 3392 participants (planned 400)
LMC Diabetes & Endocrinology Ltd.Not specified NCT07424430 Registry history of NCT07424430 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2025 to Feb 28, 2026
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 2/3 NCT06896981 Registry history of NCT06896981 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Final enrollment: 223 participants (planned 2)
Zeliha AlicikusNot specified NCT07297420 Registry history of NCT07297420 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jan 31, 2027 to Mar 31, 2027
Also in this update: Study completion pushed from May 31, 2027 to Jun 30, 2027
Moon (Guangzhou) Biotechnology Co., Ltd.Not applicable NCT07331974 Registry history of NCT07331974 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Nov 2026 to Feb 2027
Gilead SciencesPhase 1 NCT06562907 Registry history of NCT06562907 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 30, 2026 to Dec 31, 2026
Johns Hopkins UniversityPhase 2 NCT06273072 Registry history of NCT06273072 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 6, 2026 to Oct 23, 2026
Also in this update: Enrollment increased: 14 → 16 participants
AstraZenecaPhase 2 NCT07017179 Registry history of NCT07017179 on ClinicalTrials.gov (opens the registry)
Trial completed
Antalya Training and Research HospitalNot specified NCT07316179 Registry history of NCT07316179 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 12, 2027 to May 25, 2026
Yale UniversityPhase 3 NCT05157698 Registry history of NCT05157698 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 2026 to Aug 2026
Yale UniversityNot specified NCT02004561 Registry history of NCT02004561 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Feb 19, 2026
University of California, Los AngelesNot applicable NCT06030362 Registry history of NCT06030362 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 2026 to Nov 2026
Also in this update: Study completion pushed from Sep 2026 to Nov 2026
Million Marker Wellness, Inc.Not applicable NCT07560579 Registry history of NCT07560579 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 2026 to Nov 2026
Eli Lilly and CompanyPhase 1 NCT06606106 Registry history of NCT06606106 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 31, 2026 to Feb 12, 2026; Final enrollment: 35 participants (planned 45)
University of Texas Southwestern Medical CenterPhase 2 NCT06745128 Registry history of NCT06745128 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of South CarolinaPhase 2 NCT06158594 Registry history of NCT06158594 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of South CarolinaPhase 2 NCT05880901 Registry history of NCT05880901 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Sep 16, 2026
Florida State UniversityNot applicable NCT05459636 Registry history of NCT05459636 on ClinicalTrials.gov (opens the registry)
Trial status changed: Not Yet Recruiting → Active, Not Recruiting
Also in this update: Start date changed from estimate of Sep 1, 2026 to Aug 31, 2026
Medipol UniversityNot specified NCT07787546 Registry history of NCT07787546 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 2026 to Dec 7, 2025
Washington University School of MedicineNot applicable NCT01104220 Registry history of NCT01104220 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 161 participants (planned 228)
University of Colorado, DenverNot applicable NCT05107908 Registry history of NCT05107908 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of May 31, 2025 to Sep 2, 2025; Final enrollment: 207 participants (planned 400)
Medical University of ViennaNot specified NCT06680674 Registry history of NCT06680674 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 30, 2026 to Nov 30, 2026
Medical University of South CarolinaNot applicable NCT04974554 Registry history of NCT04974554 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 1, 2026 to Dec 31, 2026
Indiana UniversityNot applicable NCT05124808 Registry history of NCT05124808 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion date changed from estimate of Jun 2026 to Sep 30, 2026
Maimonides Medical CenterNot applicable NCT05939453 Registry history of NCT05939453 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Dec 1, 2026 to Feb 2027
Cedars-Sinai Medical CenterNot applicable NCT05143931 Registry history of NCT05143931 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion pushed from Dec 2027 to Mar 2028
Texas Tech UniversityNot specified NCT06790160 Registry history of NCT06790160 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 2026 to Apr 15, 2026; Final enrollment: 27 participants (planned 30)
Amy ArnoldEarly Phase 1 NCT03777215 Registry history of NCT03777215 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Nicholas SkertichEarly Phase 1 NCT06734273 Registry history of NCT06734273 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Dec 2026
University of MichiganNot specified NCT06007404 Registry history of NCT06007404 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 410 participants (planned 480)
University of Kansas Medical CenterNot applicable NCT05612971 Registry history of NCT05612971 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 30, 2026 to Sep 1, 2026; Final enrollment: 16 participants (planned 30)
Pennington Biomedical Research CenterNot applicable NCT07542873 Registry history of NCT07542873 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 2026 to May 1, 2026; Final enrollment: 14 participants (planned 24)
University of Illinois at ChicagoNot applicable NCT06504914 Registry history of NCT06504914 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 25 locations
Boehringer IngelheimPhase 3 NCT07850063 Registry history of NCT07850063 on ClinicalTrials.gov (opens the registry)
Trial completed
ETH ZurichNot specified NCT06856291 Registry history of NCT06856291 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 1, 2026 to Sep 17, 2026
Esbjerg Hospital - University Hospital of Southern DenmarkNot applicable NCT06790225 Registry history of NCT06790225 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 5 participants (planned 30)
Arizona State UniversityNot applicable NCT06963736 Registry history of NCT06963736 on ClinicalTrials.gov (opens the registry)
Trial completed
Milton S. Hershey Medical CenterNot applicable NCT07778433 Registry history of NCT07778433 on ClinicalTrials.gov (opens the registry)
Trial completed
Riphah International UniversityNot applicable NCT07576478 Registry history of NCT07576478 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 15, 2025 to Jun 22, 2025
Assistance Publique - Hôpitaux de ParisNot applicable NCT04941651 Registry history of NCT04941651 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 30, 2028 to Aug 28, 2026; Final enrollment: 44 participants (planned 120)
University of North Carolina, Chapel HillNot applicable NCT07126587 Registry history of NCT07126587 on ClinicalTrials.gov (opens the registry)
Trial completed
University of ChicagoNot applicable NCT04225507 Registry history of NCT04225507 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2026 to Dec 31, 2022; Final enrollment: 600 participants (planned 1000)
Helsinki University Central HospitalNot specified NCT03765684 Registry history of NCT03765684 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Study completion date changed from estimate of Sep 30, 2026 to Aug 27, 2026; Final enrollment: 24 participants (planned 50)
Francisco José García GonzálezNot specified NCT07588620 Registry history of NCT07588620 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Northwestern UniversityNot applicable NCT04228978 Registry history of NCT04228978 on ClinicalTrials.gov (opens the registry)
Trial completed
Arkansas Children's Hospital Research InstituteNot applicable NCT02125149 Registry history of NCT02125149 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 1191 participants (planned 1000)
University of North Carolina, Chapel HillNot applicable NCT07526584 Registry history of NCT07526584 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2028 to Sep 16, 2021
The Hospital of VestfoldNot applicable NCT03776552 Registry history of NCT03776552 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Completed
Also in this update: Study completion date changed from estimate of Jun 2026 to Nov 5, 2025; Final enrollment: 134 participants (planned 113)
The Hospital of VestfoldNot applicable NCT05207917 Registry history of NCT05207917 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Columbia UniversityNot applicable NCT03663530 Registry history of NCT03663530 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 2027 to May 19, 2026; Final enrollment: 53 participants (planned 45)
Centre Hospitalier Universitaire DijonNot applicable NCT04940962 Registry history of NCT04940962 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Jul 7, 2026
Oregon Research InstituteNot applicable NCT05437809 Registry history of NCT05437809 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 31, 2026 to Feb 28, 2026
Pennington Biomedical Research CenterNot applicable NCT05523375 Registry history of NCT05523375 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 1 → 13 locations
Boehringer IngelheimPhase 3 NCT07850050 Registry history of NCT07850050 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 203 → 209 locations
Hoffmann-La RochePhase 3 NCT07351045 Registry history of NCT07351045 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 58 → 72 locations
And 1 more change in the last 30 days
PfizerPhase 3 NCT07595549 Registry history of NCT07595549 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 204 → 210 locations
Hoffmann-La RochePhase 3 NCT07351058 Registry history of NCT07351058 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 12 → 20 locations
Alveus Therapeutics, Inc.Phase 2 NCT07837973 Registry history of NCT07837973 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 183 → 180 locations
And 1 more change in the last 30 days
PfizerPhase 3 NCT07400653 Registry history of NCT07400653 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 167 → 161 locations
PfizerPhase 3 NCT07311850 Registry history of NCT07311850 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 54 → 57 locations
AbbViePhase 2 NCT07752979 Registry history of NCT07752979 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 18 → 21 locations
And 1 more change in the last 30 days
Regeneron PharmaceuticalsPhase 2 NCT07685808 Registry history of NCT07685808 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 2026 to Nov 2026
Cairo UniversityNot specified NCT07397572 Registry history of NCT07397572 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 148 → 143 locations
And 1 more change in the last 30 days
Eli Lilly and CompanyPhase 3 NCT07282600 Registry history of NCT07282600 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 45 → 53 locations
AmgenPhase 3 NCT07575399 Registry history of NCT07575399 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 31, 2026 to Dec 31, 2026
University of MiamiNot applicable NCT06003686 Registry history of NCT06003686 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 1, 2026 to Oct 1, 2026
Also in this update: Study completion pushed from Jul 15, 2026 to Oct 15, 2026
Kasr El Aini HospitalNot applicable NCT07348146 Registry history of NCT07348146 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Mar 1, 2027 to Jul 1, 2027
Nantes University HospitalNot specified NCT07423481 Registry history of NCT07423481 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 37 → 45 locations
AmgenPhase 3 NCT07684144 Registry history of NCT07684144 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 87 → 92 locations
AmgenPhase 3 NCT07684235 Registry history of NCT07684235 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 28 locations
PfizerPhase 3 NCT07794774 Registry history of NCT07794774 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 162 → 158 locations
Eli Lilly and CompanyPhase 3 NCT07321886 Registry history of NCT07321886 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 7 → 15 locations
Arrowhead PharmaceuticalsPhase 1/2 NCT06700538 Registry history of NCT06700538 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 2 → 5 locations
Nitinotes Surgical Ltd.Not applicable NCT07090005 Registry history of NCT07090005 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 1 → 18 locations
Novo Nordisk A/SNot specified NCT07280221 Registry history of NCT07280221 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Mar 2, 2028 to Apr 28, 2028
Alnylam PharmaceuticalsPhase 1/2 NCT07463846 Registry history of NCT07463846 on ClinicalTrials.gov (opens the registry)
Interventions modified
AstraZenecaPhase 3 NCT07776509 Registry history of NCT07776509 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Aug 18, 2027 to Jul 10, 2027
Also in this update: Primary completion moved earlier from Aug 4, 2027 to Jun 26, 2027
Boehringer IngelheimPhase 2 NCT07662122 Registry history of NCT07662122 on ClinicalTrials.gov (opens the registry)
Interventions modified
Also in this update: Trial arms changed: 3 → 4
Laekna LimitedPhase 1 NCT07230496 Registry history of NCT07230496 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jul 31, 2028 to Aug 31, 2028
Also in this update: Primary completion moved earlier from Jul 31, 2028 to May 31, 2028
Michigan State UniversityPhase 2/3 NCT06597474 Registry history of NCT06597474 on ClinicalTrials.gov (opens the registry)
Start date pushed from Oct 2026 to Nov 2026
Wake Forest University Health SciencesPhase 3 NCT06987383 Registry history of NCT06987383 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 30, 2025 to Dec 30, 2027
Texas Tech University Health Sciences CenterPhase 1/2 NCT03705845 Registry history of NCT03705845 on ClinicalTrials.gov (opens the registry)
Interventions modified
The Cleveland ClinicPhase 4 NCT06854614 Registry history of NCT06854614 on ClinicalTrials.gov (opens the registry)
Study completion pushed from May 1, 2028 to Sep 1, 2028
Also in this update: Primary completion moved earlier from Dec 1, 2027 to Sep 1, 2027
Florida State UniversityNot applicable NCT07406295 Registry history of NCT07406295 on ClinicalTrials.gov (opens the registry)
Interventions modified
Universidad Autónoma de ChileNot applicable NCT07423780 Registry history of NCT07423780 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Apr 30, 2029 to Sep 30, 2028
Also in this update: Primary completion moved earlier from Apr 20, 2028 to Sep 10, 2027
Peking UniversityNot applicable NCT07519122 Registry history of NCT07519122 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
MindRank AI LtdPhase 2 NCT06606483 Registry history of NCT06606483 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Phase 1 NCT06601517 Registry history of NCT06601517 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Scitech Produtos Medicos SANot specified NCT05642663 Registry history of NCT05642663 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Kayseri City HospitalNot applicable NCT06318741 Registry history of NCT06318741 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Feb 2024); last known: Not Yet Recruiting
Zuyderland Medisch CentrumPhase 4 NCT06287307 Registry history of NCT06287307 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Not Yet Recruiting
The First People's Hospital of ChangzhouPhase 4 NCT06216340 Registry history of NCT06216340 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Chinese University of Hong KongNot applicable NCT06622382 Registry history of NCT06622382 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Escoles Universitaries GimbernatNot applicable NCT06619028 Registry history of NCT06619028 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
University of Sao PauloNot specified NCT06618430 Registry history of NCT06618430 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Al Baath UniversityNot specified NCT06615011 Registry history of NCT06615011 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
First Affiliated Hospital of Chongqing Medical UniversityNot specified NCT06614699 Registry history of NCT06614699 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
University of Sao PauloNot specified NCT06607068 Registry history of NCT06607068 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
First Affiliated Hospital of Chongqing Medical UniversityNot specified NCT06606912 Registry history of NCT06606912 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
State University of Minas GeraisNot applicable NCT06601660 Registry history of NCT06601660 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Gadjah Mada UniversityNot applicable NCT06601348 Registry history of NCT06601348 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Qianfoshan HospitalNot applicable NCT06590922 Registry history of NCT06590922 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Universiti Putra MalaysiaNot applicable NCT06590519 Registry history of NCT06590519 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Selcuk UniversityNot specified NCT06590584 Registry history of NCT06590584 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
MEDICONE PROJETOS E SOLUCOES PARA A INDUSTRIA E A SAUDE LTDANot specified NCT06585371 Registry history of NCT06585371 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Karabuk UniversityNot applicable NCT06584578 Registry history of NCT06584578 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Minia UniversityNot applicable NCT06530212 Registry history of NCT06530212 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Universitas Palangka RayaNot applicable NCT06520501 Registry history of NCT06520501 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
RenJi HospitalNot applicable NCT06187896 Registry history of NCT06187896 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Feb 2024); last known: Recruiting
NHS Greater Glasgow and ClydeNot specified NCT06101693 Registry history of NCT06101693 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jul 2024); last known: Recruiting
University of New HampshireNot applicable NCT05912348 Registry history of NCT05912348 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Erasmus Medical CenterNot specified NCT05754645 Registry history of NCT05754645 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Tufts UniversityNot specified NCT04907396 Registry history of NCT04907396 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Arkansas Children's Hospital Research InstituteNot specified NCT04819308 Registry history of NCT04819308 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Feb 2023); last known: Not Yet Recruiting
Erasmus Medical CenterNot specified NCT04484051 Registry history of NCT04484051 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
University of TriesteNot specified NCT06098417 Registry history of NCT06098417 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Active, Not Recruiting
Hospital Universitario de FuenlabradaNot applicable NCT05334173 Registry history of NCT05334173 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
Registry marked status Unknown (sponsor has not verified the record since May 2023); last known: Recruiting
Assistance Publique Hopitaux De MarseilleNot applicable NCT03008525 Registry history of NCT03008525 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-15 | NCT07875283 Analgesia After Endoscopic Sleeve Gastroplasty | American Hospital of Paris new | |
| 2026-10-13 | NCT07870668 Intermittent Phentermine for Obesity and Body Composition | OSCAR MANUEL TORRES FALCON new | Phase 4 |
| 2026-10-13 | NCT07869758 Gastric On in Obesity Management: Evaluation of the Safety and Efficacy of the 6-Month… | Rigicon, Inc. new | |
| 2026-10-09 | NCT07868978 Radial Artery Dimensions and the Effect of Anaesthetic Induction in Morbid Obesity | Hilal Subaşı Artıran new | |
| 2026-10-09 | NCT07869277 Obesity and Clinical and Cytokine Responses to Periodontal Therapy | Emine Çifcibaşı new | |
| 2026-10-08 | NCT07866365 Longitudinal Tracking Study on the Path Evolution of College Students' Proactive Health… | Yingying Tan new | |
| 2026-10-05 | NCT07857018 Long-term Follow-up After Childhood Obesity | Ulla Toft new | |
| 2026-10-05 | NCT07858331 Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access | Kristin Clemens new | Phase 4 |
| 2026-09-30 | NCT07850466 TRPTI Metabolic and GLP-1 Pharmacodynamic Study | RDC Clinical Pty Ltd new | Phase 4 |
| 2026-09-29 | NCT07846865 Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep… | Woolcock Institute of Medical Research new | Phase 2/3 |
| Early Phase 1 | 26 | |
| Phase 1 | 164 | |
| Phase 1/2 | 36 | |
| Phase 2 | 158 | |
| Phase 2/3 | 12 | |
| Phase 3 | 164 | |
| Phase 4 | 116 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07657676 | Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and… | China National Center for Cardiovascular Diseases | Recruiting | 2026-10-13 |
| NCT07870538 | A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based… | Universitaire Ziekenhuizen KU Leuven | Recruiting | 2026-10-13 |
| NCT07218445 | The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in… | Mayo Clinic | Recruiting | 2026-10-06 |
| NCT05838287 | Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants | The University of Texas Health Science Center at San Antonio | Recruiting | 2026-09-22 |
| NCT07777575 | Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide | Technical University of Munich | Recruiting | 2026-09-17 |
| NCT07699445 | The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With… | Massachusetts General Hospital | Recruiting | 2026-09-11 |
| NCT06132477 | Impact GLP-1 Agonists Following Bariatric | University of Missouri-Columbia | Recruiting | 2026-09-10 |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… | Eli Lilly and Company | Recruiting | 2026-09-09 |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… | Eli Lilly and Company | Recruiting | 2026-09-04 |
| NCT05051436 | The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics | Philip Kern | Recruiting | 2026-08-31 |
| NCT07154719 | GLP-1R Actions on Muscle and the Skeleton | Pennington Biomedical Research Center | Recruiting | 2026-08-27 |
| NCT07554638 | Incretin Therapies in Obesity-related HFpEF | Columbia University | Recruiting | 2026-08-24 |
| NCT07275697 | Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study | Emma Svennberg | Recruiting | 2026-08-10 |
| NCT06374875 | Fibrosis Lessens After Metabolic Surgery | The Cleveland Clinic | Recruiting | 2026-07-31 |
| NCT07728383 | A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity | Gila Therapeutics, Inc. | Recruiting | 2026-07-27 |
| NCT07257484 | Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors | Weill Medical College of Cornell University | Recruiting | 2026-07-22 |
| NCT06396416 | Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2 | Western University, Canada | Recruiting | 2026-06-29 |
| NCT05919797 | Weight Loss Study: Genetics and Response to Naltrexone/Bupropion | Columbia University | Recruiting | 2026-06-10 |
| NCT05320796 | The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass | Prof Urs Zingg | Recruiting | 2026-06-09 |
| NCT05975580 | Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain… | University of California, Irvine | Recruiting | 2026-06-09 |
| NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Recruiting | 2026-05-19 |
| NCT06721507 | 2024 Tirzepatide-Bariatric Surgery | Marlene Starr | Recruiting | 2026-05-14 |
| NCT05305313 | Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia… | Sir Ganga Ram Hospital | Recruiting | 2026-04-27 |
| NCT07096908 | Tirzepatide Use in People With Obesity and Type 1 Diabetes | Dasman Diabetes Institute | Recruiting | 2026-04-20 |
| NCT07513168 | Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults | Asian Institute Of Medical Sciences | Recruiting | 2026-04-06 |
Novo Nordisk A/S (65) · Eli Lilly and Company (50) · University of Colorado, Denver (32) · Mayo Clinic (28) · Norwegian University of Science and Technology (25) · Cairo University (24) · University of Alabama at Birmingham (20) · Massachusetts General Hospital (19) · Pfizer (18) · Amgen (16)